Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Arthritis Research & Therapy|May 7, 2026
Peripheral blood transcriptomic analysis of patients with rheumatoid arthritis associated interstitial lung disease reveals: distinct molecular signature with evidence of humoral and myeloid immunitySofia Flouda, Maria Grigoriou, George Sentis, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional statusNadia Boubouchairopoulou, Irini Flouri, Alexandros A Drosos, et al.
Pediatric Rheumatology Online Journal|January 28, 2025
Increased interferon I signaling, DNA damage response and evidence of T-cell exhaustion in a patient with combined interferonopathy (Aicardi-Goutières Syndrome, AGS) and cohesinopathy (Cornelia de Lange Syndrome, CdLS)Sorina Boiu, Nikolaos Paschalidis, George Sentis, et al.
Annals of the Rheumatic Diseases|April 12, 2024
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial eventsDionysis Nikolopoulos, Catherine Loukogiannaki, George Sentis, et al.
RMD Open|June 26, 2023
NF-kappa-B essential modulator (NEMO) gene polymorphism in an adult woman with systemic lupus erythematosus and recurrent non-tuberculous mycobacterial disseminated infectionsKonstantinos Thomas, Georgios Tsioulos, Christina Kotsogianni, et al.
Annals of the Rheumatic Diseases|August 7, 2017
Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, GreeceIrini Gergianaki, Antonis Fanouriakis, Argyro Repa, et al.
Clinical and Experimental Rheumatology|April 29, 2022
From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational studyNoemin N Kapsala, Dionysis S Nikolopoulos, Sofia P Flouda, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target in systemic lupus erythematosus: where are we today?Marta Mosca, Dimitrios T Boumpas, Ian N Bruce, et al.
RMD Open|January 6, 2025
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort studySpyridon Katechis, Sofia Pitsigavdaki, Myrto Nikoloudaki, et al.
Annals of the Rheumatic Diseases|July 23, 2013
Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the diseaseKonstantinos Kambas, Akrivi Chrysanthopoulou, Dimitrios Vassilopoulos, et al.
Pageof 20